United States · Funded startup

Who invested in Polygon Health Analytics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Funding summaryUpdated 26 Oct 2026

$296Kraised across 1 round since 2024, from 1 source

Latest round
Grant, $296KNov 2024
Investors
1
See who backed them

The rounds

  1. Nov 2024
    Grant$296K

    Source recorded

Founders and team

From Polygon Health Analytics's own website: 1 founder, 5 on the team.

Lixia YaoFounder & CEO
  • Leonard ReffordCFO
  • Alexandr MatatovArchitect & Lead Software Engineer
  • Ina LeeLead Strategic Partnerships
  • Madhuri MaddipatlaDirector of Business Development
  • Siqi YangHEOR Analyst

Everyone who backed them

National Cancer Institute (NCI)Investment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Polygon Health Analytics

Who invested in Polygon Health Analytics?

Polygon Health Analytics's investors include National Cancer Institute (NCI).

How much has Polygon Health Analytics raised?

Polygon Health Analytics has raised $296K across 1 round since 2024.

When did Polygon Health Analytics last raise?

Polygon Health Analytics's most recent round was a Grant of $296K in Nov 2024.

What was Polygon Health Analytics's biggest round?

Its most recent round, $296K in Nov 2024, is also its largest on record.

Who backed Polygon Health Analytics first?

Polygon Health Analytics's first round on record, in Nov 2024, was backed by National Cancer Institute (NCI).

What stage is Polygon Health Analytics at?

Polygon Health Analytics's latest named round is a Grant, in Nov 2024.

Where is Polygon Health Analytics based?

Polygon Health Analytics is based in the United States.

Companies like Polygon Health Analytics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.